Elio Rolfo

Summary

Country: Italy

Publications

  1. ncbi request reprint Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study
    Wilma Debernardi Venon
    Department of Gastroenterology, Ospedale Molinette, S Giovanni Battista Hospital, c so Bramante 88, 10126, Turin, Italy
    J Hepatol 38:455-60. 2003
  2. doi request reprint Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis
    Wilma Debernardi Venon
    Gastro Hepatology Unit, San Giovanni Battista Hospital, University of Turin, Italy Electronic address
    Eur J Intern Med 25:674-9. 2014
  3. ncbi request reprint AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers
    Wilma Debernardi-Venon
    Division of Gastroenterology and Hepatology, S Giovanni Battista Hospital, Turin, Italy
    J Hepatol 46:1026-33. 2007

Collaborators

  • Nicola Leone
  • Wilma Debernardi Venon
  • Giorgio Saracco
  • Mario Rizzetto
  • Alfredo Marzano
  • Maurizio Fadda
  • Wilma Debernardi-Venon
  • Davide Stradella
  • Mauro Bruno
  • Claudio DeAngelis
  • Chiara Elia
  • Silvia Martini
  • Carlo Alessandria
  • Giuseppe Poli
  • Angela Termine
  • Renato Bonardi
  • Barbara Vizio
  • Fiorella Biasi
  • Franco Brunello
  • Claudio Barletti
  • Luca Todros
  • Monica Baronio

Detail Information

Publications3

  1. ncbi request reprint Effects of long-term Irbesartan in reducing portal pressure in cirrhotic patients: comparison with propranolol in a randomised controlled study
    Wilma Debernardi Venon
    Department of Gastroenterology, Ospedale Molinette, S Giovanni Battista Hospital, c so Bramante 88, 10126, Turin, Italy
    J Hepatol 38:455-60. 2003
    ..We tested the efficacy of Irbesartan (Irb) vs. Propranolol (Pro) in reducing portal pressure and evaluated its systemic haemodynamic effects...
  2. doi request reprint Prospective randomized trial: endoscopic follow up 3 vs 6 months after esophageal variceal eradication by band ligation in cirrhosis
    Wilma Debernardi Venon
    Gastro Hepatology Unit, San Giovanni Battista Hospital, University of Turin, Italy Electronic address
    Eur J Intern Med 25:674-9. 2014
    ..The aim of this prospective randomized trial was to assess the most effective timing of endoscopic monitoring after variceal eradication and its impact on the patient's outcome and on the costs...
  3. ncbi request reprint AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers
    Wilma Debernardi-Venon
    Division of Gastroenterology and Hepatology, S Giovanni Battista Hospital, Turin, Italy
    J Hepatol 46:1026-33. 2007
    ..To examine the long-term effects of Candesartan cilexetil, an angiotensin type 1 (AT1) receptor blocker, on portal-systemic haemodynamics and on liver fibrosis...